nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisinopril—ABCB1—Dactinomycin—muscle cancer	0.127	0.34	CbGbCtD
Lisinopril—ABCB1—Vincristine—muscle cancer	0.0781	0.21	CbGbCtD
Lisinopril—ABCB1—Etoposide—muscle cancer	0.0716	0.192	CbGbCtD
Lisinopril—ACE—forelimb zeugopod—muscle cancer	0.0521	0.224	CbGeAlD
Lisinopril—ABCB1—Doxorubicin—muscle cancer	0.0488	0.131	CbGbCtD
Lisinopril—ABCB1—Methotrexate—muscle cancer	0.0473	0.127	CbGbCtD
Lisinopril—ACE—hindlimb—muscle cancer	0.0236	0.101	CbGeAlD
Lisinopril—ACE—arm—muscle cancer	0.0225	0.0965	CbGeAlD
Lisinopril—ACE—appendage—muscle cancer	0.0202	0.0867	CbGeAlD
Lisinopril—ACE2—renal system—muscle cancer	0.0156	0.0667	CbGeAlD
Lisinopril—ACE2—cardiac atrium—muscle cancer	0.0139	0.0597	CbGeAlD
Lisinopril—ACE2—vagina—muscle cancer	0.0113	0.0483	CbGeAlD
Lisinopril—ACE2—head—muscle cancer	0.0104	0.0446	CbGeAlD
Lisinopril—ACE2—testis—muscle cancer	0.0101	0.0431	CbGeAlD
Lisinopril—SLC15A1—renal system—muscle cancer	0.00709	0.0304	CbGeAlD
Lisinopril—ACE—embryo—muscle cancer	0.00672	0.0288	CbGeAlD
Lisinopril—ACE—smooth muscle tissue—muscle cancer	0.00528	0.0226	CbGeAlD
Lisinopril—SLC15A1—vagina—muscle cancer	0.00514	0.022	CbGeAlD
Lisinopril—ACE—renal system—muscle cancer	0.00508	0.0218	CbGeAlD
Lisinopril—ACE—cardiac atrium—muscle cancer	0.00455	0.0195	CbGeAlD
Lisinopril—ACE—bone marrow—muscle cancer	0.00384	0.0165	CbGeAlD
Lisinopril—ACE—head—muscle cancer	0.0034	0.0146	CbGeAlD
Lisinopril—ACE—testis—muscle cancer	0.00329	0.0141	CbGeAlD
Lisinopril—ABCB1—embryo—muscle cancer	0.00236	0.0101	CbGeAlD
Lisinopril—ABCB1—renal system—muscle cancer	0.00179	0.00767	CbGeAlD
Lisinopril—ABCB1—bone marrow—muscle cancer	0.00135	0.0058	CbGeAlD
Lisinopril—ABCB1—vagina—muscle cancer	0.0013	0.00556	CbGeAlD
Lisinopril—ABCB1—head—muscle cancer	0.0012	0.00513	CbGeAlD
Lisinopril—ABCB1—testis—muscle cancer	0.00116	0.00496	CbGeAlD
Lisinopril—Pain—Vincristine—muscle cancer	0.000758	0.00192	CcSEcCtD
Lisinopril—Constipation—Vincristine—muscle cancer	0.000758	0.00192	CcSEcCtD
Lisinopril—Diplopia—Doxorubicin—muscle cancer	0.000757	0.00192	CcSEcCtD
Lisinopril—Pain in extremity—Doxorubicin—muscle cancer	0.000757	0.00192	CcSEcCtD
Lisinopril—Osteoarthritis—Doxorubicin—muscle cancer	0.000757	0.00192	CcSEcCtD
Lisinopril—Asthma—Methotrexate—muscle cancer	0.000756	0.00192	CcSEcCtD
Lisinopril—Chest pain—Etoposide—muscle cancer	0.000749	0.0019	CcSEcCtD
Lisinopril—Eosinophilia—Methotrexate—muscle cancer	0.000748	0.0019	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000744	0.00189	CcSEcCtD
Lisinopril—Pancreatitis—Methotrexate—muscle cancer	0.000741	0.00188	CcSEcCtD
Lisinopril—Discomfort—Etoposide—muscle cancer	0.00074	0.00188	CcSEcCtD
Lisinopril—Face oedema—Doxorubicin—muscle cancer	0.000731	0.00185	CcSEcCtD
Lisinopril—Hypersensitivity—Dactinomycin—muscle cancer	0.000731	0.00185	CcSEcCtD
Lisinopril—Gastrointestinal pain—Vincristine—muscle cancer	0.000724	0.00184	CcSEcCtD
Lisinopril—Confusional state—Etoposide—muscle cancer	0.000724	0.00184	CcSEcCtD
Lisinopril—Cardiac arrest—Doxorubicin—muscle cancer	0.00072	0.00183	CcSEcCtD
Lisinopril—Pancytopenia—Methotrexate—muscle cancer	0.000718	0.00182	CcSEcCtD
Lisinopril—Anaphylactic shock—Etoposide—muscle cancer	0.000718	0.00182	CcSEcCtD
Lisinopril—Infection—Etoposide—muscle cancer	0.000713	0.00181	CcSEcCtD
Lisinopril—Ataxia—Doxorubicin—muscle cancer	0.000712	0.00181	CcSEcCtD
Lisinopril—Asthenia—Dactinomycin—muscle cancer	0.000711	0.0018	CcSEcCtD
Lisinopril—Blood creatinine increased—Doxorubicin—muscle cancer	0.00071	0.0018	CcSEcCtD
Lisinopril—Dysuria—Methotrexate—muscle cancer	0.000707	0.00179	CcSEcCtD
Lisinopril—Neutropenia—Methotrexate—muscle cancer	0.000707	0.00179	CcSEcCtD
Lisinopril—Dehydration—Doxorubicin—muscle cancer	0.000704	0.00179	CcSEcCtD
Lisinopril—Thrombocytopenia—Etoposide—muscle cancer	0.000703	0.00178	CcSEcCtD
Lisinopril—Upper respiratory tract infection—Methotrexate—muscle cancer	0.000703	0.00178	CcSEcCtD
Lisinopril—Tachycardia—Etoposide—muscle cancer	0.0007	0.00178	CcSEcCtD
Lisinopril—Body temperature increased—Vincristine—muscle cancer	0.0007	0.00178	CcSEcCtD
Lisinopril—Abdominal pain—Vincristine—muscle cancer	0.0007	0.00178	CcSEcCtD
Lisinopril—Skin disorder—Etoposide—muscle cancer	0.000697	0.00177	CcSEcCtD
Lisinopril—Erectile dysfunction—Methotrexate—muscle cancer	0.000696	0.00177	CcSEcCtD
Lisinopril—Hyperhidrosis—Etoposide—muscle cancer	0.000694	0.00176	CcSEcCtD
Lisinopril—Orthostatic hypotension—Doxorubicin—muscle cancer	0.000692	0.00175	CcSEcCtD
Lisinopril—Photosensitivity reaction—Methotrexate—muscle cancer	0.00069	0.00175	CcSEcCtD
Lisinopril—Breast disorder—Doxorubicin—muscle cancer	0.000684	0.00174	CcSEcCtD
Lisinopril—Anorexia—Etoposide—muscle cancer	0.000684	0.00174	CcSEcCtD
Lisinopril—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.000682	0.00173	CcSEcCtD
Lisinopril—Diarrhoea—Dactinomycin—muscle cancer	0.000678	0.00172	CcSEcCtD
Lisinopril—Pneumonia—Methotrexate—muscle cancer	0.000678	0.00172	CcSEcCtD
Lisinopril—Nasopharyngitis—Doxorubicin—muscle cancer	0.000677	0.00172	CcSEcCtD
Lisinopril—Depression—Methotrexate—muscle cancer	0.000672	0.00171	CcSEcCtD
Lisinopril—Hypotension—Etoposide—muscle cancer	0.000671	0.0017	CcSEcCtD
Lisinopril—Gastritis—Doxorubicin—muscle cancer	0.00067	0.0017	CcSEcCtD
Lisinopril—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000668	0.0017	CcSEcCtD
Lisinopril—Renal failure—Methotrexate—muscle cancer	0.000663	0.00168	CcSEcCtD
Lisinopril—Asthma—Doxorubicin—muscle cancer	0.000655	0.00166	CcSEcCtD
Lisinopril—Influenza—Doxorubicin—muscle cancer	0.000655	0.00166	CcSEcCtD
Lisinopril—Hypersensitivity—Vincristine—muscle cancer	0.000653	0.00166	CcSEcCtD
Lisinopril—Eosinophilia—Doxorubicin—muscle cancer	0.000648	0.00164	CcSEcCtD
Lisinopril—Sweating—Methotrexate—muscle cancer	0.000646	0.00164	CcSEcCtD
Lisinopril—Paraesthesia—Etoposide—muscle cancer	0.000644	0.00163	CcSEcCtD
Lisinopril—Haematuria—Methotrexate—muscle cancer	0.000643	0.00163	CcSEcCtD
Lisinopril—Pancreatitis—Doxorubicin—muscle cancer	0.000642	0.00163	CcSEcCtD
Lisinopril—Dyspnoea—Etoposide—muscle cancer	0.00064	0.00162	CcSEcCtD
Lisinopril—Somnolence—Etoposide—muscle cancer	0.000638	0.00162	CcSEcCtD
Lisinopril—Angina pectoris—Doxorubicin—muscle cancer	0.000638	0.00162	CcSEcCtD
Lisinopril—Hepatobiliary disease—Methotrexate—muscle cancer	0.000637	0.00162	CcSEcCtD
Lisinopril—Epistaxis—Methotrexate—muscle cancer	0.000636	0.00161	CcSEcCtD
Lisinopril—Asthenia—Vincristine—muscle cancer	0.000636	0.00161	CcSEcCtD
Lisinopril—Vomiting—Dactinomycin—muscle cancer	0.00063	0.0016	CcSEcCtD
Lisinopril—Bronchitis—Doxorubicin—muscle cancer	0.00063	0.0016	CcSEcCtD
Lisinopril—Agranulocytosis—Methotrexate—muscle cancer	0.000629	0.0016	CcSEcCtD
Lisinopril—Rash—Dactinomycin—muscle cancer	0.000625	0.00159	CcSEcCtD
Lisinopril—Decreased appetite—Etoposide—muscle cancer	0.000624	0.00158	CcSEcCtD
Lisinopril—Pancytopenia—Doxorubicin—muscle cancer	0.000622	0.00158	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Etoposide—muscle cancer	0.00062	0.00157	CcSEcCtD
Lisinopril—Fatigue—Etoposide—muscle cancer	0.000619	0.00157	CcSEcCtD
Lisinopril—Constipation—Etoposide—muscle cancer	0.000614	0.00156	CcSEcCtD
Lisinopril—Pain—Etoposide—muscle cancer	0.000614	0.00156	CcSEcCtD
Lisinopril—Neutropenia—Doxorubicin—muscle cancer	0.000612	0.00155	CcSEcCtD
Lisinopril—Dysuria—Doxorubicin—muscle cancer	0.000612	0.00155	CcSEcCtD
Lisinopril—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000608	0.00154	CcSEcCtD
Lisinopril—Diarrhoea—Vincristine—muscle cancer	0.000606	0.00154	CcSEcCtD
Lisinopril—Hepatitis—Methotrexate—muscle cancer	0.000605	0.00154	CcSEcCtD
Lisinopril—Pharyngitis—Methotrexate—muscle cancer	0.000601	0.00152	CcSEcCtD
Lisinopril—Urinary tract disorder—Methotrexate—muscle cancer	0.000598	0.00152	CcSEcCtD
Lisinopril—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000597	0.00152	CcSEcCtD
Lisinopril—Weight increased—Doxorubicin—muscle cancer	0.000596	0.00151	CcSEcCtD
Lisinopril—Urethral disorder—Methotrexate—muscle cancer	0.000593	0.0015	CcSEcCtD
Lisinopril—Weight decreased—Doxorubicin—muscle cancer	0.000592	0.0015	CcSEcCtD
Lisinopril—Feeling abnormal—Etoposide—muscle cancer	0.000591	0.0015	CcSEcCtD
Lisinopril—Hyperglycaemia—Doxorubicin—muscle cancer	0.00059	0.0015	CcSEcCtD
Lisinopril—Nausea—Dactinomycin—muscle cancer	0.000589	0.00149	CcSEcCtD
Lisinopril—Pneumonia—Doxorubicin—muscle cancer	0.000587	0.00149	CcSEcCtD
Lisinopril—Gastrointestinal pain—Etoposide—muscle cancer	0.000587	0.00149	CcSEcCtD
Lisinopril—Dizziness—Vincristine—muscle cancer	0.000586	0.00149	CcSEcCtD
Lisinopril—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000579	0.00147	CcSEcCtD
Lisinopril—Renal failure—Doxorubicin—muscle cancer	0.000574	0.00146	CcSEcCtD
Lisinopril—Erythema multiforme—Methotrexate—muscle cancer	0.000572	0.00145	CcSEcCtD
Lisinopril—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000572	0.00145	CcSEcCtD
Lisinopril—Urticaria—Etoposide—muscle cancer	0.00057	0.00145	CcSEcCtD
Lisinopril—Jaundice—Doxorubicin—muscle cancer	0.000569	0.00144	CcSEcCtD
Lisinopril—Body temperature increased—Etoposide—muscle cancer	0.000567	0.00144	CcSEcCtD
Lisinopril—Abdominal pain—Etoposide—muscle cancer	0.000567	0.00144	CcSEcCtD
Lisinopril—Urinary tract infection—Doxorubicin—muscle cancer	0.000567	0.00144	CcSEcCtD
Lisinopril—Tinnitus—Methotrexate—muscle cancer	0.000564	0.00143	CcSEcCtD
Lisinopril—Vomiting—Vincristine—muscle cancer	0.000563	0.00143	CcSEcCtD
Lisinopril—Sweating—Doxorubicin—muscle cancer	0.00056	0.00142	CcSEcCtD
Lisinopril—Rash—Vincristine—muscle cancer	0.000559	0.00142	CcSEcCtD
Lisinopril—Dermatitis—Vincristine—muscle cancer	0.000558	0.00142	CcSEcCtD
Lisinopril—Haematuria—Doxorubicin—muscle cancer	0.000556	0.00141	CcSEcCtD
Lisinopril—Headache—Vincristine—muscle cancer	0.000555	0.00141	CcSEcCtD
Lisinopril—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000552	0.0014	CcSEcCtD
Lisinopril—Epistaxis—Doxorubicin—muscle cancer	0.000551	0.0014	CcSEcCtD
Lisinopril—Angiopathy—Methotrexate—muscle cancer	0.000549	0.00139	CcSEcCtD
Lisinopril—Sinusitis—Doxorubicin—muscle cancer	0.000548	0.00139	CcSEcCtD
Lisinopril—Mediastinal disorder—Methotrexate—muscle cancer	0.000545	0.00138	CcSEcCtD
Lisinopril—Agranulocytosis—Doxorubicin—muscle cancer	0.000545	0.00138	CcSEcCtD
Lisinopril—Chills—Methotrexate—muscle cancer	0.000543	0.00138	CcSEcCtD
Lisinopril—Alopecia—Methotrexate—muscle cancer	0.000535	0.00136	CcSEcCtD
Lisinopril—Bradycardia—Doxorubicin—muscle cancer	0.000533	0.00135	CcSEcCtD
Lisinopril—Mental disorder—Methotrexate—muscle cancer	0.00053	0.00134	CcSEcCtD
Lisinopril—Hypersensitivity—Etoposide—muscle cancer	0.000529	0.00134	CcSEcCtD
Lisinopril—Erythema—Methotrexate—muscle cancer	0.000527	0.00134	CcSEcCtD
Lisinopril—Malnutrition—Methotrexate—muscle cancer	0.000527	0.00134	CcSEcCtD
Lisinopril—Nausea—Vincristine—muscle cancer	0.000526	0.00134	CcSEcCtD
Lisinopril—Rhinitis—Doxorubicin—muscle cancer	0.000525	0.00133	CcSEcCtD
Lisinopril—Hepatitis—Doxorubicin—muscle cancer	0.000524	0.00133	CcSEcCtD
Lisinopril—Pharyngitis—Doxorubicin—muscle cancer	0.00052	0.00132	CcSEcCtD
Lisinopril—Urinary tract disorder—Doxorubicin—muscle cancer	0.000517	0.00131	CcSEcCtD
Lisinopril—Oedema peripheral—Doxorubicin—muscle cancer	0.000516	0.00131	CcSEcCtD
Lisinopril—Dysgeusia—Methotrexate—muscle cancer	0.000516	0.00131	CcSEcCtD
Lisinopril—Asthenia—Etoposide—muscle cancer	0.000515	0.00131	CcSEcCtD
Lisinopril—Urethral disorder—Doxorubicin—muscle cancer	0.000514	0.0013	CcSEcCtD
Lisinopril—Back pain—Methotrexate—muscle cancer	0.00051	0.00129	CcSEcCtD
Lisinopril—Pruritus—Etoposide—muscle cancer	0.000508	0.00129	CcSEcCtD
Lisinopril—Vision blurred—Methotrexate—muscle cancer	0.000496	0.00126	CcSEcCtD
Lisinopril—Erythema multiforme—Doxorubicin—muscle cancer	0.000495	0.00126	CcSEcCtD
Lisinopril—Diarrhoea—Etoposide—muscle cancer	0.000491	0.00125	CcSEcCtD
Lisinopril—Ill-defined disorder—Methotrexate—muscle cancer	0.000489	0.00124	CcSEcCtD
Lisinopril—Tinnitus—Doxorubicin—muscle cancer	0.000489	0.00124	CcSEcCtD
Lisinopril—Anaemia—Methotrexate—muscle cancer	0.000487	0.00124	CcSEcCtD
Lisinopril—Flushing—Doxorubicin—muscle cancer	0.000486	0.00123	CcSEcCtD
Lisinopril—Angiopathy—Doxorubicin—muscle cancer	0.000475	0.00121	CcSEcCtD
Lisinopril—Malaise—Methotrexate—muscle cancer	0.000475	0.00121	CcSEcCtD
Lisinopril—Dizziness—Etoposide—muscle cancer	0.000475	0.0012	CcSEcCtD
Lisinopril—Vertigo—Methotrexate—muscle cancer	0.000473	0.0012	CcSEcCtD
Lisinopril—Mediastinal disorder—Doxorubicin—muscle cancer	0.000472	0.0012	CcSEcCtD
Lisinopril—Leukopenia—Methotrexate—muscle cancer	0.000471	0.0012	CcSEcCtD
Lisinopril—Chills—Doxorubicin—muscle cancer	0.00047	0.00119	CcSEcCtD
Lisinopril—Arrhythmia—Doxorubicin—muscle cancer	0.000468	0.00119	CcSEcCtD
Lisinopril—Alopecia—Doxorubicin—muscle cancer	0.000463	0.00117	CcSEcCtD
Lisinopril—Cough—Methotrexate—muscle cancer	0.00046	0.00117	CcSEcCtD
Lisinopril—Mental disorder—Doxorubicin—muscle cancer	0.000459	0.00116	CcSEcCtD
Lisinopril—Vomiting—Etoposide—muscle cancer	0.000456	0.00116	CcSEcCtD
Lisinopril—Erythema—Doxorubicin—muscle cancer	0.000456	0.00116	CcSEcCtD
Lisinopril—Malnutrition—Doxorubicin—muscle cancer	0.000456	0.00116	CcSEcCtD
Lisinopril—Rash—Etoposide—muscle cancer	0.000453	0.00115	CcSEcCtD
Lisinopril—Dermatitis—Etoposide—muscle cancer	0.000452	0.00115	CcSEcCtD
Lisinopril—Headache—Etoposide—muscle cancer	0.00045	0.00114	CcSEcCtD
Lisinopril—Flatulence—Doxorubicin—muscle cancer	0.000449	0.00114	CcSEcCtD
Lisinopril—Myalgia—Methotrexate—muscle cancer	0.000448	0.00114	CcSEcCtD
Lisinopril—Chest pain—Methotrexate—muscle cancer	0.000448	0.00114	CcSEcCtD
Lisinopril—Arthralgia—Methotrexate—muscle cancer	0.000448	0.00114	CcSEcCtD
Lisinopril—Tension—Doxorubicin—muscle cancer	0.000448	0.00114	CcSEcCtD
Lisinopril—Dysgeusia—Doxorubicin—muscle cancer	0.000447	0.00113	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000445	0.00113	CcSEcCtD
Lisinopril—Discomfort—Methotrexate—muscle cancer	0.000443	0.00112	CcSEcCtD
Lisinopril—Nervousness—Doxorubicin—muscle cancer	0.000443	0.00112	CcSEcCtD
Lisinopril—Back pain—Doxorubicin—muscle cancer	0.000441	0.00112	CcSEcCtD
Lisinopril—Muscle spasms—Doxorubicin—muscle cancer	0.000439	0.00111	CcSEcCtD
Lisinopril—Confusional state—Methotrexate—muscle cancer	0.000433	0.0011	CcSEcCtD
Lisinopril—Anaphylactic shock—Methotrexate—muscle cancer	0.00043	0.00109	CcSEcCtD
Lisinopril—Vision blurred—Doxorubicin—muscle cancer	0.00043	0.00109	CcSEcCtD
Lisinopril—Infection—Methotrexate—muscle cancer	0.000427	0.00108	CcSEcCtD
Lisinopril—Nausea—Etoposide—muscle cancer	0.000426	0.00108	CcSEcCtD
Lisinopril—Ill-defined disorder—Doxorubicin—muscle cancer	0.000423	0.00107	CcSEcCtD
Lisinopril—Anaemia—Doxorubicin—muscle cancer	0.000422	0.00107	CcSEcCtD
Lisinopril—Thrombocytopenia—Methotrexate—muscle cancer	0.000421	0.00107	CcSEcCtD
Lisinopril—Skin disorder—Methotrexate—muscle cancer	0.000418	0.00106	CcSEcCtD
Lisinopril—Hyperhidrosis—Methotrexate—muscle cancer	0.000416	0.00105	CcSEcCtD
Lisinopril—Malaise—Doxorubicin—muscle cancer	0.000411	0.00104	CcSEcCtD
Lisinopril—Vertigo—Doxorubicin—muscle cancer	0.00041	0.00104	CcSEcCtD
Lisinopril—Anorexia—Methotrexate—muscle cancer	0.00041	0.00104	CcSEcCtD
Lisinopril—Syncope—Doxorubicin—muscle cancer	0.000409	0.00104	CcSEcCtD
Lisinopril—Leukopenia—Doxorubicin—muscle cancer	0.000408	0.00104	CcSEcCtD
Lisinopril—Palpitations—Doxorubicin—muscle cancer	0.000403	0.00102	CcSEcCtD
Lisinopril—Hypotension—Methotrexate—muscle cancer	0.000402	0.00102	CcSEcCtD
Lisinopril—Loss of consciousness—Doxorubicin—muscle cancer	0.000401	0.00102	CcSEcCtD
Lisinopril—Cough—Doxorubicin—muscle cancer	0.000398	0.00101	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000392	0.000994	CcSEcCtD
Lisinopril—Insomnia—Methotrexate—muscle cancer	0.000389	0.000986	CcSEcCtD
Lisinopril—Chest pain—Doxorubicin—muscle cancer	0.000388	0.000985	CcSEcCtD
Lisinopril—Myalgia—Doxorubicin—muscle cancer	0.000388	0.000985	CcSEcCtD
Lisinopril—Arthralgia—Doxorubicin—muscle cancer	0.000388	0.000985	CcSEcCtD
Lisinopril—Anxiety—Doxorubicin—muscle cancer	0.000387	0.000982	CcSEcCtD
Lisinopril—Paraesthesia—Methotrexate—muscle cancer	0.000386	0.000979	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000386	0.000978	CcSEcCtD
Lisinopril—Discomfort—Doxorubicin—muscle cancer	0.000384	0.000973	CcSEcCtD
Lisinopril—Dyspnoea—Methotrexate—muscle cancer	0.000383	0.000972	CcSEcCtD
Lisinopril—Somnolence—Methotrexate—muscle cancer	0.000382	0.00097	CcSEcCtD
Lisinopril—Dry mouth—Doxorubicin—muscle cancer	0.00038	0.000963	CcSEcCtD
Lisinopril—Dyspepsia—Methotrexate—muscle cancer	0.000378	0.00096	CcSEcCtD
Lisinopril—Confusional state—Doxorubicin—muscle cancer	0.000375	0.000952	CcSEcCtD
Lisinopril—Decreased appetite—Methotrexate—muscle cancer	0.000374	0.000948	CcSEcCtD
Lisinopril—Anaphylactic shock—Doxorubicin—muscle cancer	0.000372	0.000944	CcSEcCtD
Lisinopril—Oedema—Doxorubicin—muscle cancer	0.000372	0.000944	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000371	0.000942	CcSEcCtD
Lisinopril—Fatigue—Methotrexate—muscle cancer	0.000371	0.00094	CcSEcCtD
Lisinopril—Infection—Doxorubicin—muscle cancer	0.00037	0.000938	CcSEcCtD
Lisinopril—Pain—Methotrexate—muscle cancer	0.000368	0.000933	CcSEcCtD
Lisinopril—Shock—Doxorubicin—muscle cancer	0.000366	0.000929	CcSEcCtD
Lisinopril—Thrombocytopenia—Doxorubicin—muscle cancer	0.000364	0.000925	CcSEcCtD
Lisinopril—Tachycardia—Doxorubicin—muscle cancer	0.000363	0.000922	CcSEcCtD
Lisinopril—Skin disorder—Doxorubicin—muscle cancer	0.000362	0.000917	CcSEcCtD
Lisinopril—Hyperhidrosis—Doxorubicin—muscle cancer	0.00036	0.000913	CcSEcCtD
Lisinopril—Anorexia—Doxorubicin—muscle cancer	0.000355	0.0009	CcSEcCtD
Lisinopril—Feeling abnormal—Methotrexate—muscle cancer	0.000354	0.000899	CcSEcCtD
Lisinopril—Gastrointestinal pain—Methotrexate—muscle cancer	0.000352	0.000892	CcSEcCtD
Lisinopril—Hypotension—Doxorubicin—muscle cancer	0.000348	0.000882	CcSEcCtD
Lisinopril—Urticaria—Methotrexate—muscle cancer	0.000342	0.000866	CcSEcCtD
Lisinopril—Body temperature increased—Methotrexate—muscle cancer	0.00034	0.000862	CcSEcCtD
Lisinopril—Abdominal pain—Methotrexate—muscle cancer	0.00034	0.000862	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000339	0.00086	CcSEcCtD
Lisinopril—Insomnia—Doxorubicin—muscle cancer	0.000337	0.000854	CcSEcCtD
Lisinopril—Paraesthesia—Doxorubicin—muscle cancer	0.000334	0.000848	CcSEcCtD
Lisinopril—Dyspnoea—Doxorubicin—muscle cancer	0.000332	0.000842	CcSEcCtD
Lisinopril—Somnolence—Doxorubicin—muscle cancer	0.000331	0.00084	CcSEcCtD
Lisinopril—Dyspepsia—Doxorubicin—muscle cancer	0.000328	0.000831	CcSEcCtD
Lisinopril—Decreased appetite—Doxorubicin—muscle cancer	0.000324	0.000821	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000321	0.000815	CcSEcCtD
Lisinopril—Fatigue—Doxorubicin—muscle cancer	0.000321	0.000814	CcSEcCtD
Lisinopril—Constipation—Doxorubicin—muscle cancer	0.000318	0.000808	CcSEcCtD
Lisinopril—Pain—Doxorubicin—muscle cancer	0.000318	0.000808	CcSEcCtD
Lisinopril—Hypersensitivity—Methotrexate—muscle cancer	0.000317	0.000803	CcSEcCtD
Lisinopril—Asthenia—Methotrexate—muscle cancer	0.000308	0.000782	CcSEcCtD
Lisinopril—Feeling abnormal—Doxorubicin—muscle cancer	0.000307	0.000778	CcSEcCtD
Lisinopril—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000304	0.000772	CcSEcCtD
Lisinopril—Pruritus—Methotrexate—muscle cancer	0.000304	0.000772	CcSEcCtD
Lisinopril—Urticaria—Doxorubicin—muscle cancer	0.000296	0.00075	CcSEcCtD
Lisinopril—Abdominal pain—Doxorubicin—muscle cancer	0.000294	0.000747	CcSEcCtD
Lisinopril—Body temperature increased—Doxorubicin—muscle cancer	0.000294	0.000747	CcSEcCtD
Lisinopril—Diarrhoea—Methotrexate—muscle cancer	0.000294	0.000746	CcSEcCtD
Lisinopril—Dizziness—Methotrexate—muscle cancer	0.000284	0.000721	CcSEcCtD
Lisinopril—Hypersensitivity—Doxorubicin—muscle cancer	0.000274	0.000696	CcSEcCtD
Lisinopril—Vomiting—Methotrexate—muscle cancer	0.000273	0.000693	CcSEcCtD
Lisinopril—Rash—Methotrexate—muscle cancer	0.000271	0.000688	CcSEcCtD
Lisinopril—Dermatitis—Methotrexate—muscle cancer	0.000271	0.000687	CcSEcCtD
Lisinopril—Headache—Methotrexate—muscle cancer	0.000269	0.000683	CcSEcCtD
Lisinopril—Asthenia—Doxorubicin—muscle cancer	0.000267	0.000678	CcSEcCtD
Lisinopril—Pruritus—Doxorubicin—muscle cancer	0.000263	0.000668	CcSEcCtD
Lisinopril—Nausea—Methotrexate—muscle cancer	0.000255	0.000648	CcSEcCtD
Lisinopril—Diarrhoea—Doxorubicin—muscle cancer	0.000255	0.000646	CcSEcCtD
Lisinopril—Dizziness—Doxorubicin—muscle cancer	0.000246	0.000624	CcSEcCtD
Lisinopril—Vomiting—Doxorubicin—muscle cancer	0.000237	0.0006	CcSEcCtD
Lisinopril—Rash—Doxorubicin—muscle cancer	0.000235	0.000595	CcSEcCtD
Lisinopril—Dermatitis—Doxorubicin—muscle cancer	0.000234	0.000595	CcSEcCtD
Lisinopril—Headache—Doxorubicin—muscle cancer	0.000233	0.000592	CcSEcCtD
Lisinopril—Nausea—Doxorubicin—muscle cancer	0.000221	0.000561	CcSEcCtD
